4597 — Solasia Pharma KK Balance Sheet
0.000.00%
- ¥9bn
 - ¥7bn
 - ¥316m
 
Annual balance sheet for Solasia Pharma KK, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.
2020 December 31st  | 2021 December 31st  | 2022 December 31st  | 2023 December 31st  | 2024 December 31st  | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — | 
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho | 
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS | 
| Status: | Final | Final | Final | Final | Final | 
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 2,964 | 714 | 803 | 728 | 886 | 
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 173 | 126 | 572 | 67 | 232 | 
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 3,269 | 894 | 1,435 | 976 | 1,266 | 
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 102 | 120 | 63 | 81 | 47 | 
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 5,775 | 3,144 | 3,134 | 2,229 | 1,362 | 
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2,079 | 489 | 407 | 293 | 193 | 
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 2,123 | 557 | 472 | 354 | 206 | 
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 3,652 | 2,587 | 2,662 | 1,875 | 1,156 | 
| Total Liabilities & Shareholders' Equity | 5,775 | 3,144 | 3,134 | 2,229 | 1,362 | 
| Total Common Shares Outstanding |